FINWIRES · TerminalLIVE
FINWIRES

RBC Downgrades ADC Therapeutics to Sector Perform From Outperform, Cuts Price Target to $2 From $6, Keeps Speculative Risk

By

ADC Therapeutics (ADCT) has an average rating of buy and mean price target of $7.40, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Bernstein Initiates Cipher Mining at Outperform With $32 Price Target

Cipher Mining (CIFR) has an average rating of buy and mean price target of $32, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CIFR
Research

Evercore ISI Initiates FedEx Freight Holding at Outperform With $168 Price Target

FedEx Freight Holding Company, Inc. (FDXF) has an average rating of overweight and mean price target of $168, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$FDXF
Research

BofA Securities Upgrades UnitedHealth to Buy From Neutral, Price Target is $450

UnitedHealth (UNH) has an average rating of overweight and mean price target of $404.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$UNH